Abstract
The etiology of inflammation of the gastric cardia (carditis) is controversial, and gastroesophageal reflux disease (GERD) and H. pylori infection have been proposed as etiological factors. This study aimed to investigate the effect of acid suppression on histological changes in the gastric cardia. Gastric cardia biopsies of reflux patients were evaluated at baseline and after proton pump inhibitor (PPI) therapy. The updated Sydney classification was used to score the biopsies, and carditis scores (pre- and post-PPI therapy) were compared. A total of 31 patients were included, of which 5 patients were excluded, as cardiac mucosa was not documented in either pre- or post-PPI biopsies. The mean duration of PPI therapy was 30 months (SE, 3.04 months). There was no significant change in carditis scores post-PPI therapy. The mean mononuclear and neutrophil scores were 1.23 and 0.35 pre-PPI therapy and 1.73 and 0.62 post-PPI therapy, respectively. No change in mean intestinal metaplasia and atrophy scores was identified.
In conclusion, acid suppressive therapy with PPI did not lead to a significant reduction in carditis scores. These results suggest that GERD probably does not play a major role in the pathogenesis of inflammation in the gastric cardia.
Similar content being viewed by others
References
Corley DA, Kubo A (2004) Influence of site classification on cancer incidence rates: an analysis of gastric cardia carcinomas. J Natl Cancer Inst 96:1383–1387
Pohl H, Welch HG (2005) The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97:142–146
El-Serag HB, Mason AC, Petersen N, Key CR (2002) Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut 50:368–372
Brown LM, Devesa SS (2002) Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin North Am 11:235–256
Kubo A, Corley DA (2004) Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol 99:582–588
Blot WJ, Devesa SS, Kneller RW, Fraumeni Jr JF (1991) Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265:1287–1289
Botterweck AA, Schouten LJ, Volovics A, et al. (2003) Trends in incidence of adenocarcinoma of the esophagus and gastric cardia in ten European countries. Int J Epidemiol 29:645–654
Daly JM, Karnell LH, Menck HR (1996) National Cancer Data Base report on esophageal carcinoma. Cancer 78:1820–1828
Kilgore SP, Ormsby AH, Gramlich TL, et al. (2000) The gastric cardia: fact or fiction? Am J Gastroenterol 95(4):921–924
Derdoy JJ, Bergwerk A, Cohen H, et al. (2003) The gastric cardia: To be or not to be? Am J Surg Pathol 27(4):499–504
Glickman, JN, Fox V, Antonioli DA, et al. (2002) Morphology of the cardia and significance of carditis in pediatric patients. Am J Surg Pathol 26(8):1032–1039
Zhou H, Greco MA, Daum F, Kahn E (2001) Origin of cardiac mucosa: ontogenic consideration. Pediatr Dev Pathol 4(4):358–363
Park YS, Park HJ, Kang GH, et al. (2003) Histology of gastroesophageal junction in fetal and pediatric autopsy. Arch Pathol Lab Med 127(4):451–455
Sharma P, Topalovski M, Mayo MS, et al. (2000) Helicobacter pylori eradication dramatically improves inflammation in the gastric cardia. Am J Gastroenterol 95(11):3107–3111
El-Zimaity, Verghese VJ, Ramchatesingh J, Graham DY (2000) The gastric cardia in gastro-oesophageal disease. J Clin Pathol 53(8):619–625
Lembo T, Ippoliti AF, Ramers C, Weinstein WM (1999) Inflammation of the gastro-oesophageal junction (carditis) in patients with symptomatic gastro-oesophageal reflux disease: a prospective study. Gut 45(4):484–488
Der R, Tsao-Wei DD, Demeester T, et al. (2001) Carditis: a manifestation of gastroesophageal reflux disease. Am J Surg Pathol 25(2):245–252
Zentilin P, Mastracci L, Dulbecco P, et al. (2004) Carditis in patients with gastro-oesophageal reflux disease: results of a controlled study based on both endoscopy and 24-h oesophageal pH monitoring. Aliment Pharmacol Ther 19(12):1285–1292
Oberg S, Peters JH, DeMeester TR, et al. (1997) Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg 226(4):522–530
Csendes A, Smok G, Burdiles P, et al. (1998) ‘Carditis’: an objective histological marker for pathologic gastroesophageal reflux disease. Dis Esophagus 11(2):101–105
Dixon MF, Genta RM, Yardley JH, Correa P (1996) Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20(10):1161–1181
Sharma P, McElhinney C, Topalovski M, et al. (2004) Detection of cardia intestinal metaplasia: Do the biopsy number and location matter? Am J Gastroenterol 99(12):2424–2428
McClave SA, Boyce Jr HW, Gottfried MR (1987) Early diagnosis of columnar-lined esophagus: a new endoscopic diagnostic criterion. Gastrointest Endosc 33(6):413–416
El-Serag HB, Sonnenberg A (1998) Opposing time trends of peptic ulcer and reflux disease. Gut 43(3):327–333
Chandrasoma PT, Der R, Ma Y, et al. (2000) Histology of the gastroesophageal junction: an autopsy study. Am J Surg Pathol 24(3):402–409
Chandrasoma PT, Lokuhetty DM, DeMeester TR, et al. (2000) Definition of histopathologic changes in gastroesophageal reflux disease. Am J Surg Pathol 24(3):344–351
Morini, S, Zullo A, Hassan C, et al. (2001) Gastric cardia inflammation: role of Helicobacter pylori infection and symptoms of gastroesophageal reflux disease. Am J Gastroenterol 96(8):2337–2340
El-Serag HB, Sonnenberg A, Jamal MM, et al. (1999) Characteristics of intestinal metaplasia in the gastric cardia. Am J Gastroenterol 94(3):622–627
Goldblum JR, Vicari JJ, Falk GW, et al. (1998) Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. Gastroenterology 114(4):633–639
Chen YY, Antonioli DA, Spechler SJ, et al. (1998) Gastroesophageal reflux disease versus Helicobacter pylori infection as the cause of gastric carditis. Mod Pathol 11(10):950–956
Goldblum JR, Richter JE, Vaezi M, et al. (2002) Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa. Am J Gastroenterol 97(2):302–311
Van Der Hulst RW, Van Der Ende A, Dekker FW, et al. (1997) Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study. Gastroenterology 113(1):25–30
Witteman EM, Mravunac M, Becx MJ, et al. (1995) Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of Helicobacter pylori. J Clin Pathol 48(3):250–256
Acknowledgment
This work was supported by the Veterans Affairs Medical Center, Kansas City, Missouri.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Singh, S., Bansal, A., Puli, S. et al. Effect of Proton Pump Inhibitor Therapy on Inflammatory Changes in the Gastric Cardia (Carditis). Dig Dis Sci 52, 2178–2182 (2007). https://doi.org/10.1007/s10620-006-9688-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-006-9688-x